Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Bertoletti

Showing results (71-80 of 224) with videos related to

Pageof 23
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
Distinct, cross-reactive epitope specificities of CD8 T cell responses are induced by natural hepatitis B surface antigen variants of different hepatitis B virus genotypesPetra Riedl, Antonio Bertoletti, Ross Lopes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2004
Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cellsNektarios Dikopoulos, Antonio Bertoletti, Andrea Kröger, et al.
Oncoimmunology|July 9, 2015
T cell receptor-therapy in HBV-related hepatocellularcarcinomaAntonio Bertoletti, Maurizia Brunetto, Mala K Maini, et al.
Emerging Microbes & Infections|June 4, 2015
Understanding the T cell immune response in SARS coronavirus infectionHsueh-Ling Janice Oh, Samuel Ken-En Gan, Antonio Bertoletti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2005
Translation from cryptic reading frames of DNA vaccines generates an extended repertoire of immunogenic, MHC class I-restricted epitopesReinhold Schirmbeck, Petra Riedl, Nicolas Fissolo, et al.
The Journal of Infectious Diseases|December 16, 2003
Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfectionR Monica Lascar, Richard J Gilson, A Ross Lopes, et al.
The Journal of Experimental Medicine|March 9, 2005
Heterologous T cell immunity in severe hepatitis C virus infectionSimona Urbani, Barbara Amadei, Paola Fisicaro, et al.
Current Research in Immunology|September 6, 2022
T cell immunity is key to the pandemic endgame: How to measure and monitor itMegan Schwarz, Slim Mzoughi, Daniel Lozano-Ojalvo, et al.
Viruses|May 5, 2017
Immune Tolerant Chronic Hepatitis B: The Unrecognized RisksPatrick T F Kennedy, Samuel Litwin, Grace E Dolman, et al.
Drug Discovery Today|May 18, 2016
Microfluidic models for adoptive cell-mediated cancer immunotherapiesGiulia Adriani, Andrea Pavesi, Anthony T Tan, et al.
Pageof 23

Showing results (71-80 of 224) with videos related to

Sort By:
Pageof 23
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
Distinct, cross-reactive epitope specificities of CD8 T cell responses are induced by natural hepatitis B surface antigen variants of different hepatitis B virus genotypesPetra Riedl, Antonio Bertoletti, Ross Lopes, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2004
Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cellsNektarios Dikopoulos, Antonio Bertoletti, Andrea Kröger, et al.
Oncoimmunology|July 9, 2015
T cell receptor-therapy in HBV-related hepatocellularcarcinomaAntonio Bertoletti, Maurizia Brunetto, Mala K Maini, et al.
Emerging Microbes & Infections|June 4, 2015
Understanding the T cell immune response in SARS coronavirus infectionHsueh-Ling Janice Oh, Samuel Ken-En Gan, Antonio Bertoletti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2005
Translation from cryptic reading frames of DNA vaccines generates an extended repertoire of immunogenic, MHC class I-restricted epitopesReinhold Schirmbeck, Petra Riedl, Nicolas Fissolo, et al.
The Journal of Infectious Diseases|December 16, 2003
Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfectionR Monica Lascar, Richard J Gilson, A Ross Lopes, et al.
The Journal of Experimental Medicine|March 9, 2005
Heterologous T cell immunity in severe hepatitis C virus infectionSimona Urbani, Barbara Amadei, Paola Fisicaro, et al.
Current Research in Immunology|September 6, 2022
T cell immunity is key to the pandemic endgame: How to measure and monitor itMegan Schwarz, Slim Mzoughi, Daniel Lozano-Ojalvo, et al.
Viruses|May 5, 2017
Immune Tolerant Chronic Hepatitis B: The Unrecognized RisksPatrick T F Kennedy, Samuel Litwin, Grace E Dolman, et al.
Drug Discovery Today|May 18, 2016
Microfluidic models for adoptive cell-mediated cancer immunotherapiesGiulia Adriani, Andrea Pavesi, Anthony T Tan, et al.
Pageof 23